α-Glucosidase-IN-79
α-Glucosidase-IN-79 (Compound 4d9) is a non-competitive α-Glucosidase inhibitor with an IC50 of 2.11 μM, which is more potent than existing α-Glucosidase inhibitors such as Acarbose (IC50 of 327.0 μM) and HXH8r (IC50 of 15.32 μM). α-Glucosidase-IN-79 is non-cytotoxic to human normal hepatocyte (LO2) cells and shows good metabolic stability in rat plasma. α-Glucosidase-IN-79 holds promise for research into type 2 diabetes[1].
Product Specifications
UNSPSC
12352100
Target
Glycosidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(NC1=C(C#N)C(CCC(C)C2)=C2S1)COC3=C(OC)C(OC)=CC(C=O)=C3
Molecular Formula
C21H22N2O5S
Molecular Weight
414.47
References & Citations
[1]Chen YT, et al. Design and synthesis of N- (3-cyanothiophen-2-yl) -2-phenoxyacetamide-based α-glucosidase inhibitors. Bioorg Med Chem Lett. 2025 Mar 1;117:130068.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC428056 20 µg
ALS2CR1 (NIF3L1) (NM_001142356) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC741897-100 1x 100 µL
Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker) (rCALD1/820), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 